Navigation Links
Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
Date:6/6/2008

ncluding risks related to: Rosetta's approach to discover and develop novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services, all of which are in early stages of development; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta's technology; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2006 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.
(1) American Cancer Society

Contact:

Media

Rachel Spielman

T: +1-212-583-2714

E: media@rosettagenomics.com

Investors'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
7. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
8. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
9. Fals-Stewart Earns Hazeldens 2007 Dan Anderson Research Award
10. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful PSE sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 23,478 boxes of ...
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 32,890 boxes of ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Impact ... Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... (H.R. 3590) is complex legislation that affects virtually ... its provisions are beginning to take effect now. ...
Breaking Medicine Technology:Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6
... Pa., May 17, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... development of therapeutic and preventive vaccines against cancers and ... its DNA vaccines and electroporation delivery technology at the ... & Cell Therapy to be held May 18-21 in ...
... May 16, 2011 Awarepoint Corporation , the ... for hospitals, announced today that it named Ralph Keiser ... as executive vice president of marketing and business development ... opportunities in the domestic and international RTLS markets. ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 2Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 3Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 4Awarepoint Expands Senior Management Team 2Awarepoint Expands Senior Management Team 3
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... has long been an option, but a new study shows ... "The most common reasons women didn,t undergo reconstruction was that ... surgery or they were focused on their cancer treatment," said ... Memorial Sloan Kettering Cancer Center, in New York City. ...
(Date:8/20/2014)... common approach to treating kidney failure by removing waste ... for people who suddenly developed the condition, in an ... School of Medicine. , Their findings, published online in ... an aggressive method that is standardly used for people ... benefit to the patient. , "Our findings question the ...
(Date:8/20/2014)... found a novel approach to treating cancer - using ... of Science Translational Medicine shows that cancer ... by nerves that are linked to cancer stem cells. ... Botox made the treatment cheap, safe and efficient. The ... and will soon start testing on humans. , The ...
(Date:8/20/2014)... August 20, 2014 A common approach ... the blood did not improve survival chances for people ... by experts at the University of Pittsburgh School ... today in the journal PLOS One , suggest ... for people with sudden kidney failure, may not provide ...
(Date:8/20/2014)... Aug. 20, 2014 (HealthDay News) -- New research reveals ... role in the global spread of the infectious disease ... from people in Africa to seals and sea lions, ... thousands of years ago, according to an international team ... on the rise again worldwide. This study and further ...
Breaking Medicine News(10 mins):Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Treating gastric cancer -- with Botox 2Health News:Pitt Analysis Questions Use of Acute Hemodialysis Treatment 2Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2
... It might seem quite natural for the elderly to often ... indicate dissatisfaction with the present, says psychologists. // ,This ... completely in the past and ignores the present. While some ... yarns, it is not a normal symptom of ageing. ...
... girl and her mother, injured in a lathi charge during ... Faridabad, a satellite town of Delhi, are in the intensive ... girl, Vidhi, had a broken collarbone and a broken wrist ... said Vidhi had shown some improvement though she continued to ...
... ramp queen Kate Moss has confided to Sir Richard Branson ... about her cocaine addiction. // ,Richard is the famous ... him and he has known her ever since she started her ... her face the reality and deal with it. ,She ...
... Ye, and Shinsuke Shimojo, from the California Institute of ... selected to reflect common contours in natural scenes" that ... analyzed one hundred writing systems, Chinese characters, and non-linguistic ... of human visual signs possess a similar shape structure," ...
... to malignant brain tumors according to a new study and ... ,Using a cell phone for long periods could lead to ... that found no such link. // ,Earlier studies ... linked with elevated brain tumor risk although the damaging effect ...
... organ donation in India passed away in Pune. She was ... promoted organ donation in India with her full zeal. She ... the work she was helped by her husband Mr.Rajan and ... donation, distributed posters in English and Marathi, organized road shows ...
Cached Medicine News:Health News:Living In The Past Indicates Dissatisfaction With Present 2Health News:Organ Donation Crusader Passes Away 2
... Agarose-HR™ High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...
... for screening donors on the PK7200 Automated ... CMV antigen attached to a gelatin particle ... and specificity of the CMV assay as ... respectively. The use of a gelatin particle ...
The reading of agglutinations process in Diana Reader is by image treatment which allows great sensitivity....
... works on patented microplate agglutination technology. Its ... for donor ABO/Rh testing. PK7200 also handles ... cytomegalovirus antibody detection. The Automated Microplate System ... the proven reliability that for the past ...
Medicine Products: